Source: PR Newswire

Press Release: Laronde : Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines

/PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
John Mendlein's photo - Interim-CEO of Laronde

Interim-CEO

John Mendlein

CEO Approval Rating

90/100

Read more